Could a cancer drug boost social abilities in rare genetic disorder?
NCT ID NCT07218575
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 24 times
Summary
This study tests whether the drug everolimus can safely improve social abilities in adults and children with PTEN Hamartoma Tumor Syndrome (PHTS), a genetic condition that raises cancer risk and often causes autism-like social difficulties. Half of the 60 participants will receive everolimus for 6 months, while the other half gets a placebo; then everyone gets the drug for another 6 months. The study measures social skills through questionnaires and checkups over one year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COWDEN'S DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.